These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 690233)

  • 1. Flucloxacillin in bone.
    Unsworth PF; Heatley FW; Phillips I
    J Clin Pathol; 1978 Aug; 31(8):705-11. PubMed ID: 690233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bone levels after intramuscular administration of cephradine ('Velosef') or flucloxacillin/ampicillin in hip replacement.
    Brooks S; Dent AR
    Pharmatherapeutica; 1984; 3(10):642-9. PubMed ID: 6463064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The penetration of flucloxacillin into cortical and cancellous bone during arthroplasty of the knee.
    Holm S; Larsson SE
    Int Orthop; 1982; 6(4):243-7. PubMed ID: 7183576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen.
    Parsons RL; Beavis JP; Laurence M; David JA; Paddock GM; Trounce JR
    Br J Clin Pharmacol; 1978 Aug; 6(2):135-43. PubMed ID: 678390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability and half-lives of cloxacillin and flucloxacillin.
    Paton DM
    Int J Clin Pharmacol Res; 1986; 6(5):347-9. PubMed ID: 3781696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone.
    Köndell PA; Nord CE; Nordenram A
    Int J Oral Surg; 1982 Feb; 11(1):40-3. PubMed ID: 6811456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and distribution of flucloxacillin in pacemaker patients.
    Anderson P; Bluhm G; Ehrnebo M; Herngren L; Jacobson B
    Eur J Clin Pharmacol; 1985; 27(6):713-9. PubMed ID: 3987776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the flucloxacillin levels in human serum, lung tissue, pericardial fluid and heart tissue.
    Kiss IJ; Faragó E; Gömöry A; Szamaránszky J
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):405-11. PubMed ID: 7450932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of flucloxacillin in femoral head and joint capsule in total hip replacement.
    Pollard JP; Hughes SP; Evans MJ; Scott JE; Benson MK
    J Antimicrob Chemother; 1979 Nov; 5(6):721-6. PubMed ID: 536357
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability and half-life of two preparations of flucloxacillin.
    Paton DM; Mander P; Avery RJ
    N Z Med J; 1982 Nov; 95(719):766-8. PubMed ID: 6959033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of flucloxacillin in heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery.
    Frank U; Schmidt-Eisenlohr E; Schlosser V; Spillner G; Schindler M; Daschner FD
    Antimicrob Agents Chemother; 1988 Jun; 32(6):930-1. PubMed ID: 3415213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug distribution in whole blood of mothers and their newborn infants: studies of cloxacillin and flucloxacillin.
    Herngren L; Ehrnebo M; Boréus LO
    Eur J Clin Pharmacol; 1982; 22(4):351-8. PubMed ID: 7106171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic disposition of flucloxacillin in patients with impaired kidney function.
    Thijssen HH; Wolters J
    Eur J Clin Pharmacol; 1982; 22(5):429-34. PubMed ID: 7117355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of amoxicillin and flucloxacillin following the simultaneous intravenous administration of 4 g and 1 g, respectively.
    Adam D; Koeppe P; Heilmann HD
    Infection; 1983; 11(3):150-4. PubMed ID: 6885174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flucloxacillin concentration in serum and wound exudate during open heart surgery.
    Farrington M; Fenn A; Phillips I
    J Antimicrob Chemother; 1985 Aug; 16(2):253-9. PubMed ID: 3877718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flucloxacillin].
    Mastroviti S; Cassarino G
    G Batteriol Virol Immunol; 1975; 68(7-12):279-88. PubMed ID: 1234594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral absorption of flucloxacillin in infants and young children.
    Bergdahl S; Eriksson M; Finkel Y; Lännergren K
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):255-8. PubMed ID: 3716820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and bone concentrations of cefuroxime and flucloxacillin. Oral versus parenteral administration in 20 arthroplasties.
    Alvarez Ferrero MM; Vree TB; Baars AM; Slooff TJ
    Acta Orthop Scand; 1993 Oct; 64(5):525-9. PubMed ID: 8237317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extravascular penetration of highly protein-bound flucloxacillin.
    Bergan T; Engeset A; Olszewski W; Ostby N; Solberg R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):729-32. PubMed ID: 3800349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flucloxacillin kinetics in newborn infants.
    Herngren L
    Eur J Clin Pharmacol; 1989; 36(3):325. PubMed ID: 2744075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.